Save time and get answers to complex questions with AI chat
Defense strategy against generic in niche market?Diltiazem drug class?Quartette side effects?When will tenofovir alafenide come off patent in canada?Does lipitor's effectiveness decrease with high fat meals?
See the DrugPatentWatch profile for Olmesartan
What is Olmesartan 40 used for? Olmesartan 40, also known as Benicar, is a medication used to treat high blood pressure. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs) [1]. By blocking the action of a natural chemical that narrows blood vessels, Olmesartan 40 helps to relax blood vessels, allowing blood to flow more easily and lowering blood pressure. How does Olmesartan 40 work compared to other blood pressure medications? Olmesartan 40 is similar to other ARBs like losartan (Cozaar) and valsartan ( Diovan) in that it blocks the angiotensin II receptor. However, it has a longer half-life and is more potent than some of its competitors [2]. It is often prescribed as a first-line treatment for hypertension or as an add-on therapy when other treatments are not effective. Is Olmesartan 40 still patented and how long does exclusivity last? According to DrugPatentWatch.com [3], the patent for Olmesartan 40 in the US expired in 2018. This allows generic versions of the medication to enter the market, increasing competition and potentially lowering prices for consumers. What are the side effects of Olmesartan 40 and how are they addressed? Common side effects of Olmesartan 40 include headache, dizziness, fatigue, and nausea [4]. In rare cases, the medication can cause more serious side effects, such as increased potassium levels, kidney problems, or allergic reactions. If you experience any of these side effects, it is essential to consult with your healthcare provider. References: [1] https://www.drugs.com/olmesartan.html [2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214444/ [3] https://www.drugpatentwatch.com/US-Patent-6177296/ [4] https://www.nlm.nih.gov/medlineplus/druginfo/meds/a602015.html
Other Questions About Olmesartan :